HEADER LIGASE 03-JUN-23 8P8X TITLE CRYSTAL STRUCTURE OF A PATHOGENIC MUTANT VARIANT OF HUMAN TITLE 2 MITOCHODNRIAL PHERS COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHENYLALANINE--TRNA LIGASE, MITOCHONDRIAL; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PHENYLALANYL-TRNA SYNTHETASE,PHERS; COMPND 5 EC: 6.1.1.20; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FARS2, FARS1, HSPC320; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PHENYLALANYL-TRNA SYNTHETASE, FARS2, MITOCHONDRIA, MITOCHONDRIAL KEYWDS 2 DISEASE, CLASS II AMINOACYL-TRNA LIGASE, ALPHA-BETA DOMAIN, ATP KEYWDS 3 BINDING, AMINO ACID BINDING, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR W.CHEN,B.KUHLE REVDAT 1 16-AUG-23 8P8X 0 JRNL AUTH W.CHEN,P.REHSI,K.THOMPSON,M.YEO,K.STALS,L.HE,P.SCHIMMEL, JRNL AUTH 2 Z.M.A.CHRZANOWSKA-LIGHTOWLERS,E.WAKELING,R.W.TAYLOR,B.KUHLE JRNL TITL CLINICAL AND MOLECULAR CHARACTERIZATION OF NOVEL FARS2 JRNL TITL 2 VARIANTS CAUSING NEONATAL MITOCHONDRIAL DISEASE. JRNL REF MOL.GENET.METAB. V. 140 07657 2023 JRNL REFN ESSN 1096-7206 JRNL PMID 37523899 JRNL DOI 10.1016/J.YMGME.2023.107657 REMARK 2 REMARK 2 RESOLUTION. 1.46 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.18.2_3874: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.46 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.32 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 82178 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.146 REMARK 3 R VALUE (WORKING SET) : 0.146 REMARK 3 FREE R VALUE : 0.167 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.430 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.3200 - 3.5200 1.00 6081 152 0.1514 0.1407 REMARK 3 2 3.5200 - 2.7900 1.00 5826 145 0.1527 0.1726 REMARK 3 3 2.7900 - 2.4400 1.00 5780 144 0.1563 0.1804 REMARK 3 4 2.4400 - 2.2200 1.00 5766 144 0.1406 0.1724 REMARK 3 5 2.2200 - 2.0600 1.00 5740 143 0.1354 0.1616 REMARK 3 6 2.0600 - 1.9400 1.00 5740 144 0.1302 0.1754 REMARK 3 7 1.9400 - 1.8400 1.00 5705 142 0.1290 0.1746 REMARK 3 8 1.8400 - 1.7600 1.00 5669 141 0.1293 0.1784 REMARK 3 9 1.7600 - 1.6900 1.00 5727 143 0.1258 0.1761 REMARK 3 10 1.6900 - 1.6300 1.00 5691 142 0.1281 0.1736 REMARK 3 11 1.6300 - 1.5800 1.00 5660 141 0.1305 0.1809 REMARK 3 12 1.5800 - 1.5400 1.00 5710 143 0.1382 0.1981 REMARK 3 13 1.5400 - 1.5000 1.00 5655 140 0.1590 0.1756 REMARK 3 14 1.5000 - 1.4600 0.96 5428 136 0.2051 0.2562 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.630 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.017 3480 REMARK 3 ANGLE : 1.895 4713 REMARK 3 CHIRALITY : 0.308 498 REMARK 3 PLANARITY : 0.015 610 REMARK 3 DIHEDRAL : 11.159 449 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8P8X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1292130917. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAR-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 82262 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.460 REMARK 200 RESOLUTION RANGE LOW (A) : 36.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.03900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.46 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.48 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.63100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.7 M SODIUM ACETATE TRIHYDRATE PH 7, REMARK 280 0.1 M BIS-TRIS PROPANE PH 7, 0.1 M MGCL2, 1% V/V 1,2-BUTANEDIOL, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.26450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.69050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.23000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.69050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.26450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.23000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 PRO A 2 REMARK 465 ALA A 3 REMARK 465 GLU A 4 REMARK 465 CYS A 5 REMARK 465 ALA A 6 REMARK 465 THR A 7 REMARK 465 GLN A 8 REMARK 465 ARG A 9 REMARK 465 ALA A 10 REMARK 465 PRO A 11 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 758 O HOH A 834 1.86 REMARK 500 O HOH A 910 O HOH A 948 1.89 REMARK 500 O HOH A 663 O HOH A 1006 1.94 REMARK 500 O HOH A 663 O HOH A 917 1.96 REMARK 500 O HOH A 774 O HOH A 972 1.98 REMARK 500 O HOH A 1038 O HOH A 1055 2.06 REMARK 500 O HOH A 931 O HOH A 1065 2.06 REMARK 500 O HOH A 950 O HOH A 1015 2.07 REMARK 500 O HOH A 889 O HOH A 1007 2.07 REMARK 500 O HOH A 653 O HOH A 901 2.17 REMARK 500 O HOH A 607 O HOH A 1014 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 843 O HOH A 1000 3545 1.93 REMARK 500 O HOH A 639 O HOH A 978 4555 1.95 REMARK 500 O HOH A 836 O HOH A 911 3545 1.96 REMARK 500 O HOH A 997 O HOH A 1050 3555 1.99 REMARK 500 O HOH A 711 O HOH A 1023 3545 2.14 REMARK 500 O HOH A 763 O HOH A 843 3555 2.16 REMARK 500 O HOH A 869 O HOH A 1003 3545 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 16 CD GLU A 16 OE2 -0.069 REMARK 500 GLU A 55 CD GLU A 55 OE2 -0.080 REMARK 500 GLU A 59 CD GLU A 59 OE2 -0.070 REMARK 500 GLU A 168 CD GLU A 168 OE2 -0.075 REMARK 500 GLU A 183 CD GLU A 183 OE1 -0.073 REMARK 500 GLU A 242 CD GLU A 242 OE1 -0.067 REMARK 500 GLU A 281 CD GLU A 281 OE2 -0.100 REMARK 500 GLU A 358 CD GLU A 358 OE1 -0.089 REMARK 500 GLU A 358 CD GLU A 358 OE2 -0.081 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 213 NE - CZ - NH1 ANGL. DEV. = 4.3 DEGREES REMARK 500 HIS A 217 CB - CA - C ANGL. DEV. = -17.5 DEGREES REMARK 500 PHE A 219 CB - CA - C ANGL. DEV. = -13.4 DEGREES REMARK 500 ARG A 395 NE - CZ - NH2 ANGL. DEV. = -4.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 29 19.25 -149.03 REMARK 500 HIS A 47 -2.06 79.94 REMARK 500 PHE A 90 -61.79 -120.31 REMARK 500 ASN A 111 -165.95 -168.35 REMARK 500 SER A 185 -136.40 -136.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 SER A 186 10.32 REMARK 500 SER A 186 10.63 REMARK 500 HIS A 217 -12.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1077 DISTANCE = 5.92 ANGSTROMS DBREF 8P8X A 3 415 UNP O95363 SYFM_HUMAN 39 451 SEQADV 8P8X GLY A 1 UNP O95363 EXPRESSION TAG SEQADV 8P8X PRO A 2 UNP O95363 EXPRESSION TAG SEQADV 8P8X LEU A 162 UNP O95363 ARG 198 CONFLICT SEQRES 1 A 415 GLY PRO ALA GLU CYS ALA THR GLN ARG ALA PRO GLY SER SEQRES 2 A 415 VAL VAL GLU LEU LEU GLY LYS SER TYR PRO GLN ASP ASP SEQRES 3 A 415 HIS SER ASN LEU THR ARG LYS VAL LEU THR ARG VAL GLY SEQRES 4 A 415 ARG ASN LEU HIS ASN GLN GLN HIS HIS PRO LEU TRP LEU SEQRES 5 A 415 ILE LYS GLU ARG VAL LYS GLU HIS PHE TYR LYS GLN TYR SEQRES 6 A 415 VAL GLY ARG PHE GLY THR PRO LEU PHE SER VAL TYR ASP SEQRES 7 A 415 ASN LEU SER PRO VAL VAL THR THR TRP GLN ASN PHE ASP SEQRES 8 A 415 SER LEU LEU ILE PRO ALA ASP HIS PRO SER ARG LYS LYS SEQRES 9 A 415 GLY ASP ASN TYR TYR LEU ASN ARG THR HIS MET LEU ARG SEQRES 10 A 415 ALA HIS THR SER ALA HIS GLN TRP ASP LEU LEU HIS ALA SEQRES 11 A 415 GLY LEU ASP ALA PHE LEU VAL VAL GLY ASP VAL TYR ARG SEQRES 12 A 415 ARG ASP GLN ILE ASP SER GLN HIS TYR PRO ILE PHE HIS SEQRES 13 A 415 GLN LEU GLU ALA VAL LEU LEU PHE SER LYS HIS GLU LEU SEQRES 14 A 415 PHE ALA GLY ILE LYS ASP GLY GLU SER LEU GLN LEU PHE SEQRES 15 A 415 GLU GLN SER SER ARG SER ALA HIS LYS GLN GLU THR HIS SEQRES 16 A 415 THR MET GLU ALA VAL LYS LEU VAL GLU PHE ASP LEU LYS SEQRES 17 A 415 GLN THR LEU THR ARG LEU MET ALA HIS LEU PHE GLY ASP SEQRES 18 A 415 GLU LEU GLU ILE ARG TRP VAL ASP CYS TYR PHE PRO PHE SEQRES 19 A 415 THR HIS PRO SER PHE GLU MET GLU ILE ASN PHE HIS GLY SEQRES 20 A 415 GLU TRP LEU GLU VAL LEU GLY CYS GLY VAL MET GLU GLN SEQRES 21 A 415 GLN LEU VAL ASN SER ALA GLY ALA GLN ASP ARG ILE GLY SEQRES 22 A 415 TRP ALA PHE GLY LEU GLY LEU GLU ARG LEU ALA MET ILE SEQRES 23 A 415 LEU TYR ASP ILE PRO ASP ILE ARG LEU PHE TRP CYS GLU SEQRES 24 A 415 ASP GLU ARG PHE LEU LYS GLN PHE CYS VAL SER ASN ILE SEQRES 25 A 415 ASN GLN LYS VAL LYS PHE GLN PRO LEU SER LYS TYR PRO SEQRES 26 A 415 ALA VAL ILE ASN ASP ILE SER PHE TRP LEU PRO SER GLU SEQRES 27 A 415 ASN TYR ALA GLU ASN ASP PHE TYR ASP LEU VAL ARG THR SEQRES 28 A 415 ILE GLY GLY ASP LEU VAL GLU LYS VAL ASP LEU ILE ASP SEQRES 29 A 415 LYS PHE VAL HIS PRO LYS THR HIS LYS THR SER HIS CYS SEQRES 30 A 415 TYR ARG ILE THR TYR ARG HIS MET GLU ARG THR LEU SER SEQRES 31 A 415 GLN ARG GLU VAL ARG HIS ILE HIS GLN ALA LEU GLN GLU SEQRES 32 A 415 ALA ALA VAL GLN LEU LEU GLY VAL GLU GLY ARG PHE HET PHE A 501 12 HETNAM PHE PHENYLALANINE FORMUL 2 PHE C9 H11 N O2 FORMUL 3 HOH *477(H2 O) HELIX 1 AA1 THR A 31 THR A 36 1 6 HELIX 2 AA2 ASN A 41 GLN A 45 5 5 HELIX 3 AA3 HIS A 48 GLN A 64 1 17 HELIX 4 AA4 THR A 86 PHE A 90 1 5 HELIX 5 AA5 ASP A 91 LEU A 94 5 4 HELIX 6 AA6 HIS A 99 ASN A 107 5 9 HELIX 7 AA7 HIS A 119 ALA A 122 5 4 HELIX 8 AA8 HIS A 123 ALA A 130 1 8 HELIX 9 AA9 SER A 165 PHE A 170 1 6 HELIX 10 AB1 ASP A 175 LEU A 179 5 5 HELIX 11 AB2 THR A 196 GLY A 220 1 25 HELIX 12 AB3 GLU A 259 ALA A 266 1 8 HELIX 13 AB4 LEU A 280 TYR A 288 1 9 HELIX 14 AB5 ASP A 292 CYS A 298 5 7 HELIX 15 AB6 ASP A 300 LYS A 305 1 6 HELIX 16 AB7 GLN A 306 CYS A 308 5 3 HELIX 17 AB8 ALA A 341 GLY A 353 1 13 HELIX 18 AB9 SER A 390 GLY A 410 1 21 SHEET 1 AA1 2 VAL A 14 LEU A 17 0 SHEET 2 AA1 2 LYS A 20 PRO A 23 -1 O TYR A 22 N VAL A 15 SHEET 1 AA2 7 SER A 75 TYR A 77 0 SHEET 2 AA2 7 ALA A 134 TYR A 142 1 O LEU A 136 N TYR A 77 SHEET 3 AA2 7 ILE A 154 PHE A 164 -1 O PHE A 155 N VAL A 141 SHEET 4 AA2 7 ILE A 272 GLY A 279 -1 O LEU A 278 N LEU A 158 SHEET 5 AA2 7 GLU A 248 MET A 258 -1 N VAL A 252 O GLY A 279 SHEET 6 AA2 7 THR A 235 PHE A 245 -1 N PHE A 245 O GLU A 248 SHEET 7 AA2 7 ILE A 225 PHE A 232 -1 N VAL A 228 O GLU A 240 SHEET 1 AA3 2 VAL A 83 THR A 85 0 SHEET 2 AA3 2 HIS A 114 LEU A 116 -1 O MET A 115 N VAL A 84 SHEET 1 AA4 4 VAL A 357 VAL A 367 0 SHEET 2 AA4 4 THR A 374 TYR A 382 -1 O ARG A 379 N ASP A 361 SHEET 3 AA4 4 VAL A 327 TRP A 334 -1 N ASN A 329 O ILE A 380 SHEET 4 AA4 4 GLU A 412 GLY A 413 -1 O GLU A 412 N TRP A 334 CISPEP 1 HIS A 236 PRO A 237 0 -7.52 CRYST1 54.529 88.460 97.381 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018339 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011305 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010269 0.00000